Lamivudine/abacavir [Kivexa; GlaxoSmithKline] has been launched in the UK and Germany

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Roche and GlaxoSmithKline have launched IV ibandronic acid [Bonviva] for postmenopausal osteoporosis in the UK

Inpharma, Vol. 1, Iss. 1536, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

An amended lawsuit has been filed against pharmaceutical giant GlaxoSmithKline

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

A major US lawsuit had been brought against UK pharmaceutical giant GlaxoSmithKline

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

GlaxoSmithKline has been granted priority review status in Japan for adefovir dipivoxil [Hepsera; licensed from Gilead Sciences]

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

The UK MHRA is to reclassify sumatriptan [Imigran Recovery; GlaxoSmithKline]

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite